Precision medicine for MDS, what drugs for which patients?
Expert advice for CLL patients: get treatment at specialized CLL centers
Conflicting results of the EMN02 and staMINA trials
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma
Have novel drugs made stem cell transplantation obsolete?